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Abstract Unraveling the genetic susceptibility of complex diseases such as chronic kidney
disease remains challenging. Here, we used inbred rat models of kidney damage associated with
elevated blood pressure for the comprehensive analysis of a major albuminuria susceptibility locus
detected in these models. We characterized its genomic architecture by congenic substitution
mapping, targeted next-generation sequencing, and compartment-specific RNA sequencing
analysis in isolated glomeruli. This led to prioritization of transmembrane protein Tmem63c as a
novel potential target. Tmem63c is differentially expressed in glomeruli of allele-specific rat models
during onset of albuminuria. Patients with focal segmental glomerulosclerosis exhibited specific
TMEM63C loss in podocytes. Functional analysis in zebrafish revealed a role for tmem63c in
mediating the glomerular filtration barrier function. Our data demonstrate that integrative analysis
of the genomic architecture of a complex trait locus is a powerful tool for identification of new
targets such as Tmem63c for further translational investigation.
DOI: https://doi.org/10.7554/eLife.42068.001
Introduction
The analysis of the genetic basis of common diseases remains challenging due to their complex
pathogenesis and genetic heterogeneity in human populations (Deng, 2015; Glazier et al., 2002;
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McCarthy et al., 2008). This applies also to elevated blood pressure (BP) or hypertension, as recent
meta-analyses of genome-wide association studies (GWAS) identified more than 100 gene loci asso-
ciated with BP (Hoffmann et al., 2017; Warren et al., 2017). The effect size of the identified gene
loci, however, is in general rather modest and less than 4% of the variance of BP phenotypes can be
explained by these loci (Hoffmann et al., 2017; Warren et al., 2017), while around 40% to 50% of
the variability appears heritable (Levy et al., 2007; Miall and Oldham, 1963). Considerable evi-
dence supports a major role of the kidney in BP regulation, and for the renal damage such as albu-
minuria development as a consequence of long-term BP elevation (Coffman and Crowley, 2008;
Mancia et al., 2013). Interestingly, genetic risk scores deploying BP genetic variants predict also
hypertensive target organ damage in the heart, cerebral vessels, and eye, while only little evidence
exists for an effect on kidney damage (Ehret et al., 2016). In this regard, several inbred hypertensive
rat models provide valuable complementary tools to uncover the genetics of kidney damage in
hypertension (Schulz and Kreutz, 2012; Yeo et al., 2015). These hypertensive models belong to
the large panel of inbred strains that have been generated for a range of physiological and disease
phenotypes by selective breeding (Atanur et al., 2013). Of interest, compensatory alleles that pro-
tect against hypertensive organ damage have also been inadvertently co-selected in this process
and explain the impressive resistance of some hypertensive strains against target organ damage
(Jacob, 2010; Jeffs et al., 1997; Rubattu et al., 1996; Schulz and Kreutz, 2012; Yeo et al., 2015).
Quantitative trait loci (QTL) mapping strategies took advantage of these findings by intercrossing
hypertensive strains with contrasting kidney damage phenotypes (Schulz and Kreutz, 2012). It
remains challenging, however, to identify the molecular changes at a complex trait QTL that account
for gene-gene or gene-environment interactions, incomplete penetrance, and epigenetic inheritance
(Buchner and Nadeau, 2015; Deng, 2015).
Here, we successfully overcome the obstacles of QTL mapping in rodents by analyzing two inbred
hypertensive rat strains with contrasting kidney damage with albuminuria phenotypes. We used the
Munich Wistar Fro¨mter (MWF) rat as a suitable hypertensive model system to target the genetic
basis of the albuminuria phenotype in contrast to the spontaneously hypertensive rat (SHR) repre-
senting a model that is protected against albuminuria development (Schulz and Kreutz, 2012;
eLife digest The human kidneys filter the entire volume of the blood about 300 times each day.
This ability depends on specialized cells, known as podocytes, which wrap around some of the
blood vessels in the kidney. These cells control which molecules leave the blood based on their size.
Normally large molecules like proteins are blocked, while smaller molecules including waste
products, toxins, excess water and salts pass through into the urine.
If this filtration system is damaged, by high blood pressure, for example, it can lead to chronic
kidney disease. A hallmark of this disease, often called CKD for short, is high levels of the protein
albumin in the urine. Previous studies involving rats with high blood pressure have found several
regions of the genome that contribute to high levels of albumin in the urine, including one on
chromosome 6. However, this region contains several genes and it was unclear which genes affected
the condition.
Schulz et al. set out to narrow down the list and find specific genes that might contribute to
elevated albumin in the urine of rats with high blood pressure. This search identified the gene for a
protein called TMEM63c as a likely candidate. This protein spans the outer membrane of podocyte
cells. Analysis of kidney biopsies showed that patients with chronic kidney disease also had low
levels of this protein in their podocytes. Further experiments, this time in zebrafish, showed that
reducing the activity of the gene for tmem63c led to damaged podocytes and a leakier filter in the
kidneys.
The results suggest that this gene plays an important role in the integrity of the kidneys filtration
barrier. It is possible that faulty versions of this gene are behind some cases of chronic kidney
disease. If this proves to be the case, a better understanding of the role of this gene may lead to
new treatments for the condition.
DOI: https://doi.org/10.7554/eLife.42068.002
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Figure 1. Congenic substitution mapping of the albuminuria and nephron deficit QTL on rat chromosome 6. (A) Urinary albumin excretion (UAE) in
Munich Wistar Fro¨mter (MWF) and spontaneously hypertensive rats (SHR) at 8 weeks of age. MWF (n = 18); SHR (n = 10); values plotted:
median ±interquartile range (IQR); Mann-Whitney U test; *p<0.0001. (B) Genetic map of RNO6 with genetic markers and distance in centi Morgan (cM).
(C) 1-LOD (thick bar) and 2-LOD (thin bar) confidence intervals for placement of the albuminuria QTL by linkage mapping. (D) The chromosomal
fragment for the MWF (black) and SHR (white) genome are indicated for the MWF (n = 18/11§), consomic MWF-6SHR (n = 19/11§), and SHR (n = 10/11§)
strains. (E–F) The chromosomal fragment for congenic strains designated as MWF.SHR-(D6Rat1-D6Rat184) (n = 17/0§), MWF.SHR-(D6Rat1-D6Rat115)
(n = 10/0§), MWF.SHR-(D6Rat1-D6Rat81) (n = 25/11§), MWF.SHR-(D6Rat1-D6Mgh4) (n = 24/11§), MWF.SHR-(D6Rat1-D6Rat121) (n = 29/6§), MWF.SHR-
(D6Rat1-D6Mit8) (n = 18/6§), MWF.SHR-(D6Rat1-D6Rat106) (n = 10/0§), and MWF.SHR-(D6Rat1-D6Rat30) (n = 10/0§) (E). Corresponding phenotypes for
UAE and glomerular density (GD) (F). Red values indicate disease phenotypes and blue values an amelioration of phenotypes for informative strains. § n
is presented for the phenotypes in the following order UAE/GD; values shown for UAE: median ±IQR, Kruskall-Wallis test with Dunn’s multiple
comparisons test; *p<0.0001; values shown for GD: mean ±SD; one-way ANOVA with post hoc Bonferroni’s multiple comparisons test and Mann-
Whitney U test; *p<0.0001 vs. SHR, MWF-6SHR, MWF.SHR-(D6Rat1-D6Mgh4), respectively; #p<0.0001 vs. MWF.SHR-(D6Rat1-D6Mgh4), respectively;
##p=0.029 vs. MWF.SHR-(D6Rat1-D6Rat30). (G–K) Evaluation of nephron deficit in MWF and SHR rats by determination of GD. Right kidneys at 4 weeks
of age were cut into 5 mm thick histological sections (G). For evaluation of glomerular diameter and glomerular number adjacent pictures were taken for
each periodic acid-Schiff (PAS) stained histological section (white rectangles) (H). Calculation of GD (10x magnification) (I). Direct comparison of GD
Figure 1 continued on next page
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van Es et al., 2011). Following initial QTL mapping in intercrosses of contrasting hypertensive strains
(Schulz and Kreutz, 2012), we successfully combined conventional fine mapping using congenic
strains with characterization of the genomic architecture in sub-QTLs by targeted next-generation
sequencing (NGS), and compartment-specific RNA sequencing (RNA-Seq) analysis. This comprehen-
sive approach allowed us to prioritize transmembrane protein Tmem63c as a novel positional target
for albuminuria development among several candidates. Functional relevance of Tmem63c was sup-
ported by allele-specific and BP-independent differential glomerular expression during onset of
albuminuria in allele-specific minimal congenic rat lines derived from the contrasting rat models.
Loss of glomerular TMEM63C expression in podocytes of patients with focal segmental glomerulo-
sclerosis (FSGS) provided strong evidence for translational relevance. Loss-of-function studies in
zebrafish induced a glomerular filtration barrier (GFB) defect compatible with the albuminuria phe-
notype, which was rescued upon co-injection of zebrafish tmem63c mRNA or rat Tmem63c mRNA,
showing not only the specificity of the observed knockdown phenotype, but also conservation of the
gene’s function across species. Ultrastructural analysis by electron microscopy, demonstrated severe
morphological defects including podocyte damage with foot process effacement in tmem63c-
Figure 1 continued
evaluation (J) vs. total glomerular number as previously estimated by the physical fractionator method (K). Total glomerular number (n = 7 each); GD
(n = 11 each); values plotted: mean ±SD; two-tailed student’s t-test; *p<0.0001 vs. SHR; **p=0.0024 vs. SHR.
DOI: https://doi.org/10.7554/eLife.42068.003
The following source data is available for figure 1:
Source data 1. Albuminuria in parental, consomic, and congenic rat strains.
DOI: https://doi.org/10.7554/eLife.42068.004
Source data 2. Glomerular density and total nephron number in parental, consomic, and congenic rat strains.
DOI: https://doi.org/10.7554/eLife.42068.005
Figure 2. Mean arterial blood pressure (MAP) in consomic and congenic rat strains. Measurement of MAP is
shown for SHR (n = 9), MWF-6SHR (n = 6), congenic MWF.SHR-(D6Rat1-D6Mgh4) (Rat1-Mgh4, n = 8) and congenic
MWF.SHR-(D6Rat1-D6Rat81) (Rat1-Rat81, n = 8) and MWF (n = 7) at week 14; values plotted: mean ±SD; one-way
ANOVA with Bonferroni’s post hoc analysis; *p<0.0001 vs. other strains, respectively.
DOI: https://doi.org/10.7554/eLife.42068.006
The following source data is available for figure 2:
Source data 1. Mean Arterial Pressure in parental, consomic, and congenic rat strains.
DOI: https://doi.org/10.7554/eLife.42068.007
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deficient embryos. Altogether, our findings reveal TMEM63C being integral to podocyte physiology,
and identified its potential role in glomerular renal damage in patients with chronic kidney disease.
Our data demonstrate, despite the difficulties of QTL analysis in experimental models such as inbred
strains, the feasibility to identify novel targets by combining conventional congenic substitution map-
ping with integrative analysis of genomic architecture of identified susceptibility loci and functional
studies.
Figure 3. Next-generation sequencing (NGS) analysis of the kidney damage region on rat chromosome 6 and RNA sequencing (RNA-Seq) analysis in
isolated glomeruli. (A–B) DNA sequencing (DNA-Seq) analysis revealed the numbers of DNA variants in comparison to the reference genome across
the sequenced region for the Munich Wistar Fro¨mter (MWF) and spontaneously hypertensive rat (SHR) strains (n = 3, each) (A). The physical map
between nucleotide position 106,405,000 and 111,405,000 is shown together with positions of potential candidate genes (in green) (B); in addition, the
two genes at the 5’-position and 3’-position of the candidate region are visualized in black. (C) The Tajima’s D variation across the sequenced region.
(D–E) Volcano plots illustrating the differential expression results (MWF vs. SHR) in RNA-Seq analysis in isolated glomeruli using the Cuffdiff (D) and
DESeq2 (E) analysis tools. For each gene, the log10 transformed differential expression P-value adjusted for false discovery rate is plotted against the
log2 transformed expression fold change. The color gradient refers to the P-values given on the y-axis. The applied significance threshold of adjusted
p-value<0.05 is indicated as dashed horizontal line. Dashed vertical lines indicate fold changes > 1.5. Genes of interest are highlighted in grey and are
annotated with gene symbols. (See Figure 3—figure supplement 1).
DOI: https://doi.org/10.7554/eLife.42068.008
The following source data and figure supplement are available for figure 3:
Source data 1. Predicted effects of variants identified by NGS in the candidate region on rat chromosome 6 in human.
DOI: https://doi.org/10.7554/eLife.42068.010
Figure supplement 1. Venn diagram of NGS analysis.
DOI: https://doi.org/10.7554/eLife.42068.009
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Results
Congenic substitution mapping in the MWF rat model refines the
albuminuria QTL to a chromosomal region linked to both albuminuria
and nephron deficit
We previously confirmed the pivotal role of a major albuminuria QTL on rat chromosome 6 (RNO6)
in the MWF model by generating a consomic MWF-6SHR strain, which carries RNO6 from the con-
trasting albuminuria-resistant SHR strain in the MWF genetic background (Figure 1A–D)
(Schulz et al., 2007). In addition, MWF rats inherit a deficit in nephron (and glomeruli) number,
which represents a predisposition for the development of both hypertension and kidney damage
(Wang and Garrett, 2017). We performed congenic substitution mapping for both albuminuria and
glomerular density phenotypes by generating eight congenic lines by introgression of nested chro-
mosomal fragments from SHR onto the MWF genetic background, and compared the renal
Table 1. Significant variants in the candidate kidney damage region on rat chromosome 6.
Gene Gene coordinates
Variant
position
Variant
type
Allelic
variants
Amino acid
exchange
Effect of sequence
variant
PROVEAN
score
Start position
(bp)
Stop position
(bp) MWF SHR
Acot4 107,517,668 107,522,952 107,518,131 exonic A G Gly fi Arg non-synonymous  5.660
Acot5 107,550,904 107,557,688 107,551,446 exonic A C Arg fi Ser non-synonymous  2.842
107,551,528 exonic A G Arg fi His non-synonymous  2.646
107,551,717 exonic G C Pro fi Arg non-synonymous  5.314
107,557,092 exonic A T Leu fi Gln non-synonymous  5.291
Acot6 107,581,608 107,590,373 107,590,006 exonic C T Leu fi Pro non-synonymous  5.091
Ptgr2 108,009,251 108,029,859 108,029,833 exonic T C Arg fi Cys non-synonymous  3.672
Ngb 111,126,261 111,132,320 111,128,730 exonic G A Leu fi Pro non-synonymous  3.000
111,131,291 exonic ACT A NA frameshift deletion NA
MWF, Munich Wistar Fro¨mter; SHR, spontaneously hypertensive rat. NA, not applicable.
DOI: https://doi.org/10.7554/eLife.42068.011
Table 2. Presence of the frameshift deletion in inbred rat strains in neuroglobin (Ngb) at 111,131,291 bp.
Strain Presence of deletion Strain Presence of deletion
ACI no MHS no
BBDP no MNS no
BN.Lx no SBH no
EVE no SBN no
F344/Ncrl no SHR yes
FHH no SHR/NHsd yes
FHL no SHRSP/Gla yes
GK yes SR/Jr no
LE/Stm no SS/Jr no
LEW no SS_JRHSDMCWI no
LEW/NcrlBR no WAG no
LH no WKY yes
LL no WKY/Gla yes
LN no WKY_NHSD yes
The inbred rat strains with presence of the Ngb frame shift deletion in bold belong to a clade of Wistar rat derived strains from Japan.
DOI: https://doi.org/10.7554/eLife.42068.012
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phenotypes between congenic lines and the parental MWF strain (Figure 1E,F). We successfully nar-
rowed the original region identified by QTL mapping, spanning about 55 Mb between genetic
markers D6Rat106 and D6Rat9 (Schulz et al., 2003), to a smaller interval comprising 4.9 Mb
between D6Mgh4 and D6Rat81 (Figure 1E,F). The comparison between the two informative con-
genic lines MWF.SHR-(D6Rat1-D6Mgh4) and MWF.SHR-(D6Rat1-D6Rat81) revealed that 95% of the
difference in albuminuria and 89% of the difference in glomerular density observed between the
MWF and consomic MWF-6SHR strains is attributable to this interval (Figure 1E,F). Subsequently, we
set out to analyze the BP phenotype by direct intra-arterial measurements in the two congenic lines
in comparison to the MWF and SHR strains. This analysis revealed similar mean arterial BP values in
the two congenic lines and parental MWF strain (Figure 2). This findings clearly indicate the UAE dif-
ference between MWF.SHR-(D6Rat1-D6Mgh4) and MWF.SHR-(D6Rat1-D6Rat81) are not attributable
to BP differences (Figure 2). Thus, we dissected away a role of this region for BP regulation and
show that both the albuminuria and glomerular density phenotype co-localize in the same refined
locus (sub-QTL), supporting further exploration of this region as an independent candidate region
for kidney damage. Direct comparison of glomerular density (Figure 1G–J) with the total glomerular
number as previously estimated by the physical fractionator method (Figure 1K) (Schulz et al.,
2007) confirmed the nephron deficit in MWF compared to SHR (Figure 1J, p<0.0001). We further
demonstrated that this phenotype maps also to RNO6 (Figure 1F) when determined by glomerular
density analysis in kidney sections (Figure 1G–J).
Targeted NGS analysis of the identified kidney damage candidate
region
We employed targeted NGS on the region ranging from nucleotide positions 105,780,000 to
111,425,000 on RNO6. After genotype calling and comparing genotypes of consomic and congenic
rats, we refined coordinates of the kidney damage locus from 106,400,000 bp to 111,360,000 bp
(Figure 3A,B). This region contains 75 predicted protein-coding genes. In comparison to the refer-
ence genome (Rattus norvegicus, ENSEMBL rn6.0) (Yates et al., 2016), we identified 5,158 SNPs
and 1893 small insertions and deletions (INDELs) in MWF, and 5326 single nucleotide polymor-
phisms (SNPs) and 1804 INDELs in SHR (Figure 3—figure supplement 1). Direct comparison
between MWF and SHR revealed that both strains differ for 5376 SNPs and for 1613 INDELs (Fig-
ure 3—figure supplement 1), showing a remarkable pattern of stretches of variants either coming
from the MWF or the contrasting SHR strain (Figure 3A). As selective sweeps have recently been
reported as a consequence of inbreeding in rats (Atanur et al., 2013), we performed a formal analy-
sis of selective processes such as directional selection or balancing selection, genetic hitchhiking, or
introgression using the Tajima’s D statistics (Tajima, 1989). We observe such traces of selection with
the majority of Tajima’s D values exceeding the generally accepted threshold of D > 2 (Figure 3C).
Table 3. Genes in the candidate kidney damage region with differential expression in RNA-Seq analysis.
Gene
Start
(bp position)
End
(bp position) ID P(DeSeq2) P(Cuffdiff) Straina
Acot3 107,531,528 107,536,789 ENSRNOG00000053460 0.09426742 0.00799931 SHR
Rps6kl1 108,961,994 108,976,489 ENSRNOG00000005530 0.024515465 0.0186294 MWF
Acot5 107,550,904 107,557,688 ENSRNOG00000032508 0.000234652 0.000948356 SHR
Papln 107,245,820 107,276,755 ENSRNOG00000009448 8.82E-05 0.000948356 MWF
Tmem63c 111,049,559 111,120,799 ENSRNOG00000011334 6.26E-06 0.000948356 MWF
Flvcr2 109,617,355 109,681,495 ENSRNOG00000008754 2.06E-06 0.000948356 MWF
Jdp2 109,466,060 109,505,161 ENSRNOG00000008224 0.052146312 0.00245615 SHR
Esrrb 110,410,141 110,455,906 ENSRNOG00000010259 0.278291584 0.00245615 SHR
Tgfb3 109,913,757 109,935,533 ENSRNOG00000009867 0.019914732 0.0632265 SHR
Vash1 110,624,856 110,637,382 ENSRNOG00000010457 0.070552875 0.00314268 MWF
MWF, Munich Wistar Fro¨mter; RNA-Seq, RNA sequencing; SHR, spontaneously hypertensive rat. Genes shown in bold were found to be significantly differ-
entially expressed using both CuffDiff and DeSeq2 analysis. a The strain name is given for upregulation of mRNA expression.
DOI: https://doi.org/10.7554/eLife.42068.016
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Figure 4. Validation of differentially expressed genes in isolated glomeruli by quantitative real-time PCR (qPCR) analysis. (A) qPCR analysis showed no
consistent differential expression for eight genes from overall 10 genes identified with differential expression in RNA sequencing (RNA-Seq) analysis
(Table 3) between parental Munich Wistar Fro¨mter (MWF), spontaneously hypertensive rats (SHR), and consomic MWF-6SHR during the crucial time
window for onset of albuminuria between weeks 4 and 8. Only transmembrane protein 63c (Tmem63c) demonstrated differential mRNA expression at
Figure 4 continued on next page
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Functional annotation using PROVEAN scores identified eight potentially deleterious non-synony-
mous variants in five genes (Table 1). In addition, in the contrasting SHR reference strain one frame-
shift deletion was detected in the gene encoding neuroglobin (Ngb). However, this deletion is also
present in the entire clade of SHR-related rat strains derived from one ancestor including other
strains with normal urinary albumin excretion and normal kidney function (Table 2) (Atanur et al.,
2013). Consequently, this frameshift deletion is not to be considered involved in the kidney damage
phenotype and was not further pursued. Thus, we identified no obvious single candidate by NGS
analysis in the sub-QTL.
Positional candidate gene identification by transcriptome analysis in
isolated glomerular tissue by RNA-Seq
In order to identify other positional candidates at the sub-QTL on RNO6, we next embarked on
RNA-Seq analysis in isolated glomeruli from MWF and SHR to assess global mRNA transcription pat-
terns in the target compartment. We performed gene-based differential expression analysis using
Cuffdiff and DESeq2 software tools (Figure 3D,E). After correcting for multiple testing, 1838 genes
were assigned a p-value<0.05 for Cuffdiff analysis and 1841 genes for DESeq2, respectively, yielding
a total set of 2454 unique differentially expressed genes. When filtering the results for those genes
residing in the candidate region, we identified a total of 10 genes to be significantly differentially
expressed between MWF and SHR (Table 3, Figure 3D,E) at significant p-values. These genes were
taken forward to validation by quantitative real-time PCR (qPCR) analysis in isolated glomeruli
obtained from the two parental and MWF-6SHR consomic animals during onset of albuminuria occur-
ring between 4 and 8 weeks of age (Figure 4A). This analysis revealed that from the nine genes,
which could be analyzed, only Tmem63c, showed consistent and allele-dependent differential
expression during the crucial time window (Figure 4A,B).
Tmem63c represents a positional candidate gene in MWF with
differential glomerular expression
RNA-Seq and qPCR analysis indicated a significant 2.5- to 3-fold upregulation of Tmem63c mRNA
expression in isolated glomeruli in the MWF model, which was abolished by transfer of RNO6 from
SHR onto the MWF genetic background in the corresponding MWF-6SHR consomic line (Figure 4A).
Moreover, comparison of Tmem63c mRNA expression between the two informative congenic lines
MWF.SHR-(D6Rat1-D6Rat81) and MWF.SHR-(D6Rat1-D6Mgh4) confirmed an allelic (cis) regulation
of Tmem63c mRNA expression in MWF and SHR, and its association with albuminuria (Figure 4B).
Further evaluation of the NGS data for Tmem63c in MWF and SHR revealed no significant sequence
variants, with the exception of one detected variant in intron 18 (ENSRNOT00000015571) at
Figure 4 continued
both time points. Acyl-CoA thioesterase 3 (Acot3) (Table 3) showed very low mRNA expression in qPCR analysis precluding quantitative analysis.
Consequently, Acot3 and the genes shown were excluded from and Tmem63c was included for further functional analysis. Rats per strain (n = 7–8,
each); values for Acot5 (week 8),Tgfb3 (week 4) and Tmem63c (week 8) are plotted as median ±IQR, while the rest of data are plotted as mean ±SD;
data for Acot5 (week 8), Tgfb3 (week 4) and Tmem63c (week 8) were analyzed using Kruskal-Wallis test with Dunn’s post-hoc analysis and Mann-
Whitney U test, while the rest of data was analyzed by one-way ANOVA with Bonferroni’s post hoc analysis and Mann-Whitney U test. (B) mRNA
expression analysis for Tmem63c in isolated glomeruli by qPCR analysis is shown for MWF, SHR, congenic MWF.SHR-(D6Rat1-D6Mgh4) (Rat1-Mgh4)
and congenic MWF.SHR-(D6Rat1-D6Rat81) (Rat1-Rat81), at week 4 and week 8. Rats per strain (n = 6–8, each); data for week 8 are plotted as
median ±IQR and analyzed using Kruskal-Wallis test with Dunn’s post hoc analysis and Mann-Whitney U test; the other data are plotted as mean ±SD
and analyzed by one-way ANOVA with Bonferroni’s post hoc analysis and Mann-Whitney U test (C) Representative immunohistochemical stainings of
TMEM63C and Wilms tumor 1 (WT1) on kidney sections from SHR and MWF at 8 weeks of age; the insert indicates expression in podocytes. Scale
bar = 50 mm. Quantitative analysis of TMEM63C intensity in podocytes using one-way ANOVA revealed lower intensity in MWF (n = 7) vs. SHR (n = 6) at
8 weeks (p=0.0032).
DOI: https://doi.org/10.7554/eLife.42068.013
The following source data is available for figure 4:
Source data 1. Quantitative real-time PCR analysis of differentially expressed genes in isolated glomeruli between rat strains.
DOI: https://doi.org/10.7554/eLife.42068.014
Source data 2. Primer list for quantitative real-time PCR analysis.
DOI: https://doi.org/10.7554/eLife.42068.015
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Figure 5. Transmembrane protein 63c (TMEM63C) protein and Nephrin expression deficiency in patients with focal segmental glomerulosclerosis
(FSGS). (A–D) High-intensity TMEM63C staining in a glomerulus of a healthy human control subject (A) and representative glomeruli of FSGS patients
with high (+++) (B), intermediate (+) TMEM63C staining intensity (C), or loss (-) of TMEM63C protein expression (D). The inserts indicate TMEM63C-
positive podocytes. Scale bar = 50 mm. (E) Scoring of the TMEM63C staining intensity in controls (n = 11) and FSGS patients (n = 9). Percentage of
cases with high intensity (green); intermediate intensity (blue); low intensity (yellow) and no TMEM63C staining (magenta). Linear-by-Linear association;
p=0.005. (F) Scoring of the percentage of TMEM63C positivity in glomeruli. Green: no loss; blue:<25% loss; yellow: 25–50% loss; magenta:>50% loss of
Figure 5 continued on next page
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111,101,251 bp at a potential splice site position. However, when analyzing our RNA-Seq data con-
cerning differential exon usage in Tmem63c, we found no significant difference in exon usage
between both parental strains.
We then set out to perform immunohistochemistry analysis of TMEM63C in MWF kidney. This
revealed TMEM63C expression in a podocyte-specific pattern (Figure 4C). In contrast to the clearly
elevated mRNA expression in isolated glomeruli, this analysis indicated no elevated glomerular pro-
tein expression in MWF, and only somewhat lower TMEM63C protein expression in podocytes in
MWF compared to SHR at onset of albuminuria at 8 weeks of age (Figure 4C).
Patients with focal segmental glomerulosclerosis exhibit loss of
glomerular TMEM63C expression
Aging MWF rats develop histopathological changes similar to those observed in patients with FSGS
(Remuzzi et al., 1992; Schulz and Kreutz, 2012). Podocyte injury with the development of glomeru-
lar proteinuria represents a pivotal hallmark of FSGS (D’Agati et al., 2011; Lim et al., 2016). Thus,
we explored TMEM63C expression in patients with FSGS and healthy controls to evaluate its poten-
tial role for human kidney damage (Yu et al., 2016). This analysis demonstrated that TMEM63C is
expressed in podocytes of all glomeruli in healthy controls (Figure 5A,E), while patients with FSGS
exhibit a significant decrease of TMEM63C expression (Figure 5B–E) with a global loss of glomerular
TMEM63C in the majority of patients analyzed (Figure 5D–F). In addition to TMEM63C expression,
we analyzed the expression of nephrin protein as a pivotal component of the slit diaphragm of the
GFB (Figure 5G–J) (Kestila¨ et al., 1998). Nephrin expression was also significantly reduced in
patients with FSGS (Figure 5H,I), which is in accordance with previously published results
(Kim et al., 2002). Moreover, we observed a shift from the normal linear staining pattern to a granu-
lar staining pattern as reported (Figure 5H,J) (Doublier et al., 2001; Wernerson et al., 2003).
Knockdown of TMEM63C expression in human podocytes impairs cell
viability and survival signaling
We further analyzed the effect of reduced TMEM63C expression in human podocytes in culture
using small interfering RNA (siRNA) methodology (Figure 6A). We found significantly impaired cell
viability in response to TMEM63C downregulation (Figure 6B). In addition, reduction of TMEM63C
expression by siRNA decreased pro-survival signaling in human podocytes as indicated by reduced
levels of pAKT (Figure 6C), and increased pro-apoptotic transition of cytochrome C from mitochon-
dria to the cytoplasm (Figure 6D).
Functional analysis of tmem63c in zebrafish
To assess the functional role of tmem63c for albuminuria development, we utilized the transgenic
zebrafish line Tg[fabp10a:gc-EGFP] (Zhou and Hildebrandt, 2012). This model expresses a vitamin
D binding protein tagged with enhanced green fluorescent protein (gc-EGFP) in the liver, from which
it is released into the blood stream and circulates under the normal conditions in the blood
(Figure 7A,G). Upon GFB damage, gc-EGFP leaks through the glomerular filtration barrier, indicated
by a marked decrease in fluorescence in the trunk vasculature of Tg[fabp10a:gc-EGFP] embryos
Figure 5 continued
TMEM63C expression. Controls (n = 11) and FSGS patients (n = 9); values plotted: median ±IQR; Mann-Whitney U test; *p<0.0001 vs. control;
**p=0.021 vs. control. (G–J) Linear nephrin staining in a glomerulus of a healthy human control subject (G) and segmental loss of nephrin staining in a
glomerulus of a patient with FSGS (H), indicated by arrowheads. Nephrin expression was significantly reduced in patients with FSGS compared to
healthy controls (I). Moreover, we observed a shift from a normal linear staining pattern, following the glomerular capillary wall, to a granular staining
pattern (H and J). values plotted: median ±IQR; Mann-Whitney U test; *p=0.05 vs. control; **p<0.01 vs. control; ***p<0.001 vs. controls.
DOI: https://doi.org/10.7554/eLife.42068.017
The following source data is available for figure 5:
Source data 1. TMEM63C intensity score and percentage of TMEM63C positivity in glomeruli in FSGS patients.
DOI: https://doi.org/10.7554/eLife.42068.018
Source data 2. Nephrin staining in FSGS patients.
DOI: https://doi.org/10.7554/eLife.42068.019
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mimicking an albuminuria-like phenotype (Figure 7A). To reduce tmem63c levels in developing
zebrafish embryos, we used the morpholino knockdown technology as well as CRISPR/Cas9-medi-
ated somatic mutagenesis (Bassett et al., 2013; Burger et al., 2016) (Figure 7B). In both morpho-
lino-injected embryos and crispants (CRISPR/Cas9-mediated somatic mutants), loss of tmem63c did
Figure 6. Functional role of TMEM63C in human podocytes (hPC) in vitro. Shown is the impact of siRNA-mediated inhibition of TMEM63C
(siTMEM63C) or treatment of hPC with a corresponding nonsense negative control (siControl). (A) TMEM63C protein expression normalized against
GAPDH as a loading control (*p=0.011). Shown is a representative Western blot. (B) Cell viability determined via measurement of calcein acetoxymethyl
(AM) fluorescence intensity in hPC (**p=0.024). (C) Phosphorylation state of protein kinase B (pAKT) normalized against the expression of total AKT
(AKT) (#p=0.0094). Shown is a representative Western blot, GAPDH is used as a loading control. (D) Pro-apoptotic cytochrome C transition from
mitochondria to the cytoplasm of hPC (##p=0.0096). The mean ±SD of at least three independent experiments is shown, respectively. Two-tailed
Student´s t-test was performed for all experiments.
DOI: https://doi.org/10.7554/eLife.42068.020
The following source data is available for figure 6:
Source data 1. TMEM63C expression in human podocytes using small interfering RNA (siRNA) methodology.
DOI: https://doi.org/10.7554/eLife.42068.021
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Figure 7. Functional assessment of the glomerular filtration barrier (GFB) after loss of transmembrane protein 63c (tmem63c) in zebrafish. (A) Scheme of
the GFB in healthy and albuminuric zebrafish embryos. Green fluorescent protein (gc-EGFP) represents an albumin surrogate and is filtrated after
impairment of the GFB. fe, fenestrated endothelium; fp, foot processes of podocytes; GBM, glomerular basement membrane. (B) Schematic of
tmem63c showing the target regions in Exon 2 (ex2) used for Morpholino (MO)- and CRISPR/Cas9-mediated somatic mutagenesis. (C–F) Bright field
view of wildtype embryos at 48 hr post-fertilization (hpf) in uninjected controls (C), ATG-MO injected (D), 159.6 ng/ml ex2-sgRNA injected (E), and 250
ng/ml ex2-sgRNA injected embryos (F). Scale bar = 1 mm. (G–K) Fluorescence microscopy of Tg[fabp10a:gc-EGFP] embryos at 120 hpf. Uninjected
control with clearly visible gc-EGFP fluorescence in the trunk vasculature (‘fluorescent’) (G). tmem63c ATG-MO-injected embryo with partial or a
complete loss of trunk fluorescence (‘deficient-fluorescent’) (H) and tmem63c ATG-MO +Tmem63c mRNA (Rat) co-injected embryo (I) showing rescue
of the phenotype. Tmem63c ex2-sgRNA-injected embryo with partial or a complete loss of trunk fluorescence (‘deficient-fluorescent’) (J) and tmem63c
ex2-sgRNA + tmem63c mRNA (ZF) co-injected embryo (K) showing rescue of the phenotype. Scale bar = 1 mm. (L) Analysis of gc-EGFP in the trunk
vasculature. Shown are embryos categorized as ‘deficient-fluorescent’ (df), see Materials and method section and Figure 7—figure supplement 2 for
details. Experimental groups are normalized to the corresponding uninjected control group per experiment. Uninjected Control (n = 1198); Control-MO
Figure 7 continued on next page
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not result in any visible developmental malformations apart from mild pericardial edema
(Figure 7C–F). Knockdown of tmem63c using morpholino technology resulted in a significant
decrease in gc-EGFP fluorescence in the trunk vasculature at 120 hr post fertilization (hpf)
(Figure 7H). We corroborated this finding in tmem63c crispants (Figure 7J, Figure 7—figure sup-
plement 1D) as well as by using another splice-blocking morpholino (Figure 7—figure supplement
1E–I); both experiments showed a similar albuminuria-like phenotype. To verify the specificity of the
observed phenotype rescue experiments were carried out by co-injection of zebrafish tmem63c
mRNA with tmem63c sgRNA/Cas9 complexes and rat Tmem63c mRNA (mRNA sequence identity
vs. zebrafish = 65.82% (Clustal 2.1), Figure 7—figure supplement 2) with tmem63c ATG-MO,
respectively. For both cases similarly, the albuminuria-like phenotype could be specifically rescued
proving knockdown specificity on the one hand and functional conservation of tmem63c across spe-
cies on the other hand (Figure 7I,K and L). Our data indicate that tmem63c may regulate the GFB
integrity.
To understand the possible functional changes in GFB in more detail, we deployed electron
microscopy to visualize the GFB ultrastructure in embryos with reduced tmem63c levels. We
observed significant changes in podocyte foot process morphology manifested by foot process
effacement (Figure 8A–C). Quantitative analysis in tmem63c crispants revealed a significant increase
in the foot process width compared to uninjected controls and Cas9-controls (Figure 8D) with con-
comitant significant decrease of the number of slit diaphragms per mm glomerular basement mem-
brane (GBM) (Figure 8E). To analyze, whether the observed albuminuria-like phenotype upon
tmem63c-deficiency is associated with the loss of podocytes, we utilized confocal microscopy to
image glomeruli of Tg(wt1b:EGFP) embryos. In this analysis, tmem63c crispants (tmem63c ex2-
sgRNA) showed a widened Bowman´s space and increased glomerular volumes compared to unin-
jected controls (133457 ± 59547 mm3 vs 67067 ± 21933 mm3, p=0.04) as quantified by 3D surface
reconstruction. In addition, we observed dilated capillary loops in the crispants (Figure 8F–H). Quan-
tification of podocyte cell number in embryos with reduced tmem63c levels revealed no changes in
absolute cell number (Figure 8I, Videos 1–3), while relative podocyte cell number normalized to the
total glomerular volume was significantly decreased compared to uninjected controls (Figure 8J,
Videos 1–3). Collectively, our data indicate the conserved role for tmem63c in GFB function
between fish, rodents, and humans.
Discussion
Previous genetic analysis in the fawn-hooded hypertensive (FHH) rat model led to the identification
of naturally occurring genetic variants in RAB38, member RAS oncogene family (Rab38), and shroom
family member 3 (Shroom3) that successfully complemented studies in humans supporting their role
for albuminuria (Rangel-Filho et al., 2013; Yeo et al., 2015). Interestingly, the genetic variant in
Rab38 was linked to altered tubular (Rangel-Filho et al., 2013; Teumer et al., 2016), and the variant
Figure 7 continued
(n = 189); tmem63c ATG-MO (n = 227); tmem63c ATG-MO +Tmem63c mRNA (Rat) (n = 230); tmem63c ex2-sgRNA (n = 371); tmem63c ex2-
sgRNA + tmem63c mRNA (ZF) (n = 126); One-way ANOVA with Bonferroni’s multiple comparisons test. Values plottet: mean ±SD, dashed line at y = 1
indicates the uninjected control level; *p=0.0002 vs. uninjected Control, #p<0.0001 vs. tmem63c ATG-MO. **p=0.0014 vs. uninjected Control,
##p<0.0001 vs. tmem63c ex2-sgRNA. Data points in the graph represent the ratio per independent experiment, %(Uninjected Control (df)) / %
(experimental group (df)), N  3. (See Figure 7—figure supplement 1 and Figure 7—figure supplement 2).
DOI: https://doi.org/10.7554/eLife.42068.022
The following source data and figure supplements are available for figure 7:
Source data 1. Functional assessment of the GFB after tmem63c-knockdown using tmem63c ex2-sgRNA and ex2-sgRNA and tmem63c ATG-MO.
DOI: https://doi.org/10.7554/eLife.42068.026
Figure supplement 1. Functional assessment of the glomerular filtration barrier (GFB) in Tg[fabp10a:gc-EGFP] zebrafish embryos.
DOI: https://doi.org/10.7554/eLife.42068.023
Figure supplement 1—source data 1. Functional assessment of the GFB after tmem63c-knockdown using tmem63c ex2-sdMO.
DOI: https://doi.org/10.7554/eLife.42068.024
Figure supplement 2. Excerpt from sequence alignment of tmem63c mRNA zebrafish (NM_001159836) vs Tmem63c mRNA rat (NM_001108045.1).
DOI: https://doi.org/10.7554/eLife.42068.025
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Figure 8. Ultrastructural and morphological analysis of glomerular structures after loss of tmem63c in zebrafish. (A–E) Electron microscopy and
quantitative assessment of GFB ultrastructure. Representative electron microscopy pictures of the GFB in uninjected Controls (A), Cas9-Controls (B) and
after tmem63c knockdown (C), asterisks indicate effaced podocyte foot processes). Quantitative analysis of podocyte foot process width (D) and
number of slit diaphragms per mm GBM (E). Uninjected Control (n = 5); Cas9-Control (n = 4); tmem63c ex2-sgRNA (n = 4); Scale bar = 1 mm; values
Figure 8 continued on next page
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in Shroom3 to altered glomerular (Yeo et al., 2015) albumin handling. Thus, animal models have
been proven useful not only for the explanation of missing heritability (Chatterjee et al., 2013), but
also for the elucidation of the differences between glomerular and tubular origins of albuminuria
(Rangel-Filho et al., 2013; Yeo et al., 2015). Currently, in GWAS meta-analyses in general popula-
tion cohorts, only cubilin (CUBN) has been significantly associated with albuminuria (Bo¨ger et al.,
2011). In addition, variants in HS6ST1 and near RAB38/CTSC were implicated in albuminuria in
patients with diabetes (Teumer et al., 2016). Nevertheless, in parallel to the findings obtained in BP
GWAS (Hoffmann et al., 2017; Warren et al., 2017), only a small fraction of the estimated heritabil-
ity of albuminuria can be attributed to the identified genes (Langefeld et al., 2004; Teumer et al.,
2016). The MWF rat, in which we identified at least 11 albuminuria QTL, highlights the polygenic
nature of complex traits such as kidney damage with albuminuria in hypertension (Schulz and
Kreutz, 2012). Here, we focused on a major albuminuria QTL (Schulz and Kreutz, 2012;
Schulz et al., 2003) and refined the candidate region to a sub-QTL comprising 4.9 Mb. We con-
firmed that both the albuminuria and the neph-
ron deficit phenotype map to the same genomic
region supporting a genetic link between albu-
minuria and embryonic/fetal nephron develop-
ment (Wang and Garrett, 2017). In addition, the
informative congenic lines with differential albu-
minuria development showed similar BP values
by which we showed that this genomic region
affects albuminuria development independently
from BP changes. In the targeted NGS analysis,
multiple non-deleterious variants but no clear
candidate was identified. However, significant
signs of selective sweeps in this region, poten-
tially leading to an enrichment of multiple non-
deleterious alleles due to genetic hitchhiking,
were detected. This is in agreement with a recent
systematic genome sequencing study of labora-
tory inbred rat strains indicating that private sin-
gle-nucleotide variants are highly concentrated in
a small number of discrete regions of the
genome (Atanur et al., 2013). The authors of
this report hypothesized that variants that are
unique to a single strain reside within these
regions because many of these regions were pos-
itively selected in the initial phenotype-driven
derivation of these strains. Surprising - and chal-
lenging however - remains our observation that
no obvious causative variant for the kidney dam-
age phenotype was observed in our targeted
NGS analysis. Notwithstanding, complex traits
Figure 8 continued
plottet: mean ±SD; One-way ANOVA with Bonferroni’s multiple comparisons test; *p=0.0019 vs. uninjected Control, *p=0.0017 vs Cas9-Control; #
p=0.0171 vs. uninjected Control, # p=0.0148 vs. Cas9-Control. (F–J) Confocal microscopy and analysis of absolute and relative podocyte cell number in
Tg(wt1b:EGFP) at 96 hpf. Representative confocal microscopy pictures of glomeruli in uninjected Controls (F), Cas9-Controls (G) and after tmem63c
knockdown (H). Quantitative analysis of absolute (I) and relative (J) podocyte cell number. Relative podocyte cell number has been obtained after
normalization to the glomerular volume. Uninjected Control (n = 6); Cas9-Control (n = 6); tmem63c ex2-sgRNA (n = 7); Scale bar = 15 mm; values
plottet: mean ±SD; One-way ANOVA with Bonferroni’s multiple comparisons test; **p=0.0421 vs. uninjected Control.
DOI: https://doi.org/10.7554/eLife.42068.027
The following source data is available for figure 8:
Source data 1. Tables and legends.
DOI: https://doi.org/10.7554/eLife.42068.028
Video 1. Representative spot segmentation of
podocyte nuclei and 3D surface reconstruction of
glomeruli in uninjected controls of Tg(wt1b:EGFP)
zebrafish embryos. The videos show a maximum
intensity projection of the masked DAPI channel
acquired by confocal microscopy of Tg(wt1b:EGFP)
zebrafish embryos at 96 hpf. The DAPI channel of
DAPI+/EGFP+-cells visualized here represents podocyte
nuclei. Blue spots show the podocyte nuclei identified
by software-based spot segmentation. Spots were
counted for quantification of the absolute podocyte
cell number. The grey surface represents the 3D
surface reconstruction of glomeruli containing all
DAPI+/EGFP+ nuclei, which was used for quantification
of the total glomerular volume. Shown here are
representative analysis results of uninjected controls
(Video 1), Cas9-Controls (Video 2) and tmem63c ex2-
sgRNA-injected embryos (Video 3).
DOI: https://doi.org/10.7554/eLife.42068.029
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can also be a consequence of gene expression changes resulting in dysregulation of physiological
pathways, a concept which becomes increasingly recognized as RNA sequencing is employed to dis-
tinguish tissue-specific gene expression patterns in a variety of complex diseases (Joehanes et al.,
2017; Kirsten et al., 2015).
We therefore complemented the DNA re-sequencing by compartment-specific RNA-Seq analysis
which is rational, because MWF rats develop early glomerular changes that precede albuminuria
development and show early podocyte injury in parallel with the onset of albuminuria
(Ijpelaar et al., 2008). We identified Tmem63c as a positional candidate based on its mRNA expres-
sion pattern with differential glomerular expression in allele-specific rat models. Immunohistochemis-
try analysis in MWF kidneys identified TMEM63C protein in podocytes, and in contrast to the
observed marked glomerular mRNA upregulation only a modest downregulation. Bioinformatics
analysis of our NGS and RNA-Seq data has not yet provided a potential explanation for this discrep-
ancy, for example interstrain differences related to exon usage or other events shown to mediate
protein expression control on the post-transcriptional level. The relationship between protein levels
and their coding transcripts is, however, rather complex and factors such as spatial and temporal
variations of mRNAs, as well as the local availability of resources for protein biosynthesis, strongly
influence this relationship (Liu et al., 2016). Spatial variation in expression regulation during renal
injury development could be specifically important in podocytes due to their unique ultrastructural
and molecular anatomy (Endlich et al., 2017). To explore the potential clinical relevance of
TMEM63C for kidney damage, we selected patients with FSGS because they mirror the disease pat-
tern observed in the MWF model (D’Agati et al., 2011; Lim et al., 2016; Yu et al., 2016). Impor-
tantly, patients with FSGS exhibit a significant decrease of TMEM63C protein levels in podocytes
with a global loss of glomerular expression in the majority of patients. Furthermore, the loss of
TMEM63C was associated with a decrease and altered granular staining pattern of nephrin protein
in glomeruli of FSGS patients as previously reported (Doublier et al., 2001; Wernerson et al.,
2003). The latter has been previously shown to correspond to the degree of foot process efface-
ment (Wernerson et al., 2003). While our data cannot establish a functional link between changes in
nephrin and TMEM63c in FSGS, they nonetheless demonstrate a concomitant deficiency of both
proteins in this setting.
To further validate Tmem63c, we tested its functional relevance for albuminuria development in
zebrafish (Danio rerio). Our data confirm that in both tmem63c morphants and crispants, loss of
tmem63c leads to a phenotype indicative of a GFB defect. Importantly, rescue of the observed phe-
notypes in zebrafish with rat Tmem63c mRNA pointed to the functional conservation across species.
Ultrastructural analysis in zebrafish embryos demonstrated the role of tmem63c for the GFB integrity
by revealing overt effacement of podocyte foot processes upon gene deficiency. Further structural
analysis by confocal microscopy revealed dilated capillary loops and enlarged glomerular volumes
with a reduction of relative podocyte number in relation to glomerular volume (podocyte density) in
tmem63c-deficient embryos. Thus, our data reveal an important role of tmem63c for normal devel-
opment of capillary structure and podocyte function of the glomerulus in zebrafish.
Video 2. Representative spot segmentation of
podocyte nuclei and 3D surface reconstruction of
glomeruli in Cas9 - injected controls (Cas9 - controls) of
Tg(wt1b:EGFP) zebrafish embryos.
DOI: https://doi.org/10.7554/eLife.42068.030
Video 3. Representative spot segmentation of
podocyte nuclei and 3D surface reconstruction of
glomeruli in tmem63c ex2-sgRNA - injected Tg(wt1b:
EGFP) zebrafish embryos
DOI: https://doi.org/10.7554/eLife.42068.031
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Tmem63c belongs to the TMEM (transmembrane protein) gene family comprising more than 300
different proteins with about 580 transcript variants (Wrzesin´ski et al., 2015). These proteins are
predicted components of cellular membranes. However, the function of the majority of TMEM pro-
teins - including Tmem63c - is currently unclear. There are no previous reports that demonstrate
TMEM63C expression in the kidney, while assessment of the human protein atlas database indicates
TMEM63C expression in human kidney in both the glomerular and tubular compartments
(Lundberg et al., 2010); ‘Tissue expression of TMEM63C - Staining in kidney’ - The Human Protein
Atlas, 2019; Uhle´n et al., 2015). Tmem234, another member of the TMEM family, may represent a
component of the basal membrane of podocytes and has recently been associated with proteinuria
development in zebrafish (Rodriguez et al., 2015). The mechanism by which changes in Tmem63c
expression cause podocyte damage and thus contribute to the final common pathway of injury in
FSGS (De Vriese et al., 2018) remains however unclear and cannot be elucidated by our current
analysis. Accordingly, our data do not allow to describe possible interactions between TMEM63c
and the heterogeneous group of known causative FSGS genes. Nevertheless, previous reports sug-
gested that Tmem63c and two other genes of the tmem63-family, i.e. Tmem63a and Tmem63b, are
mammalian homologues of the hyperosmolarity-activated cation channel proteins AtCSC1 and its
paralogue OSCA1 in plants (Hou et al., 2014; Zhao et al., 2016). Based on these reports, it
appeared tempting to speculate that Tmem63c may be involved in mechanosensing in podocytes
providing thus a functional basis for interactions with cytoskeleton genes or slit pore proteins,
for example nephrin, in podocytes. However, the potential role of Tmem63c as a hyperosmolarity-
activated cation channel remains controversial, since the activation by hyperosmolarity was not con-
firmed in a more recent study (Murthy et al., 2018). Moreover, the latter report indicated that
Tmem63c is phylogenetically divergent from Tmem63a and Tmem63b and lacks their function to
induce stretch-activated ion currents. Consequently, further studies are needed to characterize the
functional role of Tmem63c and to explore its potential to influence podocyte function as a novel
target for therapeutic intervention (Endlich et al., 2017; Forst et al., 2016; Wieder and Greka,
2016). In contrast to our experiments in zebrafish, in the explorative analysis in biopsies of FSGS
patients we cannot differentiate between a primary (causative) or secondary effect of TMEM63C
expression loss in patients. Nevertheless, taken together with our experimental analysis, the data
clearly support Tmem63c as a novel candidate for further translational research on kidney damage.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Antibody anti-TMEM63C Perbio Science
Germany; this paper
epitope:
GLRGFAREL
DPAQFQEGLE
1:1600 for rat tissue,
1:800 for human
biopsies
Antibody rabbit anti-WT1 Santa Cruz RRID:AB_632611 1:500
Antibody rabbit anti-nephrin Abcam RRID:AB_944400 1:750
Antibody Goat anti-rabbit
EnVision HRP
conjugate
Dako
Antibody GAPDH Calbiochem
Antibody AKT Merck Chemicals GmbH
Antibody phospho-AKT Ser473 Merck Chemicals
GmbH
Biological sample
(Homo sapiens)
Renal biopsy
samples of patients
with FSGS
archive of the
Department of
Pathology
of the Leiden
University
Medical Center
(LUMC)
For patient information
see Table 4
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
ell line
(Homo sapiens)
hPC Saleem et al., 2002 RRID:CVCL_W186
Gene
(Danio rerio)
tmem63c NA ZFIN: ZDB-GENE-120928–2
Gene
(Homo sapiens)
TMEM63C NA Ensembl: ENST00000298351.4
Gene
(Rattus norvegicus)
Tmem63c NA Ensembl: ENSRNOT00
000015571.6
Other DAPI stain Sigma Aldrich stock solution
1 mg/ml
diluted 1:2000 in PBS
Other DNA-Seq database this paper GEO and SRA:
Submission ID:
SUB2950675 and
BioProject ID:
PRJNA398197
See Data availability
Other RNA-Seq database this paper GEO and SRA:
accession GSE102546
See Data availability
Recombinant
DNA reagent
tmem63c
(cDNA) zebrafish
this paper Infusion cloning primer
sequences for cDNA synthesis:
forward: GCTTGATATC
GAATTCATG
GCGTTTGAGTCCT
GGCCTGC; reverse:
CGGGCTGCAGGA
ATTCTCACTGAA
AAGCCACCGGACTG;
Sequence additional
primer for amplification
of ORF:
GTGCAGAAAC
TAATGAAGCTGG; Progenitors:
tmem63c (cDNA);
pBluescript II SK(+)
Sequence-
based reagent
tmem63c
ATG-MO
Gene Tools
LLC Philomath
sequence:
5’-CAGGCCAGGAC
TCAAACGCCATTGC-3’
Sequence-
based reagent
tmem63c
ex2-sdMO
Gene Tools
LLC Philomath
sequence: 5’-
TGTTATCATAGATGA
TGTACCAGCC-3’
Sequence-
based reagent
tmem63c
ex2-sgRNA
this paper Sequence
synthesis forward
primer with CRISPR
target site underlined:
GAAATTAATACGACT
CACTATAGGACGTC
AGGAGTTTCCTGAGTT
TTAGAGCTAGAAATAGC
Sequence-
based reagent
tmem63c ex2-
sgRNA primers
flanking
CRISPR target site
BioTez Berlin-
Buch GmbH
Sequences: forward:
CAAATGGTGAAC
ACTTGTGAATC,
reverse: CTGCGGTT
TACTGCGGAGATG
Sequence-based
reagent
siTMEM63C Sigma-Aldrich
Chemie GmbH
Strain, strain
background
(Danio rerio)
Tg(fabp10a:gc-EGFP) Zhou and Hildebrandt, 2012
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers
Additional
information
Strain, strain
background
(Danio rerio)
Tg(wt1b:GFP) Perner et al., 2007
Strain, strain
background
(Rattus norvegicus)
MWF/Rkb Own colony Charite´
– Universita¨tsmedizin
Berlin, Germany
http://dels.nas.edu/ilar/ (laboratory
code Rkb);
Schulz and Kreutz, 2012;
RRID:RGD_724569
Strain, strain
background
(Rattus norvegicus)
SHR/Rkb Own colony Charite´ –
Universita¨tsmedizin
Berlin, Germany
http://dels.nas.edu/ilar/
(laboratory code Rkb);
Schulz and Kreutz, 2012;
RRID:RGD_631696
Strain, strain
background
(Rattus norvegicus)
MWF-6SHR Own colony Charite´ –
Universita¨tsmedizin
Berlin, Germany
http://dels.nas.edu/ilar/
(laboratory code Rkb);
Schulz and Kreutz, 2012;
RRID:RGD_1641831
Strain, strain
background
(Rattus norvegicus)
Congenic
strains see
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Rat animals
Male rats were obtained from our MWF/Rkb (RRID:RGD_724569, laboratory code Rkb, http://dels.
nas.edu/ilar/) and SHR/Rkb (RRID:RGD_631696, laboratory code Rkb, http://dels.nas.edu/ilar/) colo-
nies at the Charite´ – Universita¨tsmedizin Berlin, Germany. The consomic MWF-6SHR (RRID:RGD_
1641831) was previously described (Schulz et al., 2007). Rats were grouped under conditions of reg-
ular 12 hr diurnal cycles with an automated light switching device and climate-controlled conditions
at a room temperature of 22˚C. The rats were fed a normal diet containing 0.2% NaCl and had free
access to food and water.
A panel of eight congenic rat lines MWF.SHR-(D6Rat1-D6Rat30), MWF.SHR-(D6Rat1-D6Rat106),
MWF.SHR-(D6Rat1-D6Mit8), MWF.SHR-(D6Rat1-D6Rat121), MWF.SHR-(D6Rat1-D6Mgh4), MWF.
SHR-(D6Rat1-D6Rat81), MWF.SHR-(D6Rat1-D6Rat115), and MWF.SHR-(D6Rat1-D6Rat184) was gen-
erated by transfer of different nested SHR segments onto the MWF background. For this procedure,
male and female rats of the MWF-6SHR breeding, that were homozygous for all MWF chromosomes
except RNO6 and heterozygous for RNO6, were intercrossed (Schulz et al., 2003). All experimental
work in rat models was performed in accordance with the guidelines of the Charite´-Universita¨tsmedi-
zin Berlin and the local authority for animal protection (Landesamt fu¨r Gesundheit und Soziales, Ber-
lin, Germany) for the use of laboratory animals. The registration numbers for the rat experiments are
G 0255/09 and T 0189/02.
Determination of albuminuria, direct BP and glomerular density in rats
Urinary albumin excretion was measured as reported (Kreutz et al., 2000). Direct intra-arterial BP
measurements were performed in awake male rats at 14 weeks of age as previously described
(Kreutz et al., 1995; Schulz et al., 2010). For determination of glomerular density, animals were
sacrificed under ketamine-xylazine anesthesia (87 and 13 mg/kg body wt, respectively) at week 4.
The right kidney was fixed in methacarn and embedded in paraffin. Tissue samples were cut into 5-m
m-thick histological sections (Figure 1G–I) and stained with the periodic acid-Schiff (PAS) technique.
Section analysis was performed by a photomicroscope Axiophot (Zeiss) and a digital camera system
AxioCam MRc Rev. 3 FireWire (Zeiss) at a 10x magnification. Glomerular density was calculated
using the formula n = G/FA(D + T) as reported (ELIAS et al., 1961; Lucas et al., 1997). Glomeruli in
20–25 fields for each sample were counted in the outer cortex zone (Figure 1H,I). Glomerular diam-
eter was calculated by the AxioVision release 4.8.2 software program (Zeiss). This method was vali-
dated by comparison with the absolute nephron numbers as determined by the physical fractionator
method in rat strains as previously reported (Gundersen, 1986; Schulz et al., 2007).
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NGS of the candidate region on RNO6
Based on the fine mapping results of the congenic MWF strains, a target candidate region of about
5.63 Mbp (chr6:105.8–111.43 Mb, R. norvegicus, ENSEMBL rn6.0) (Yates et al., 2016) was defined
for subsequent next-generation resequencing analysis. The solution-based SureSelectXT (Agilent
Technologies) capture method was applied for custom target enrichment of the defined region
according to the manufacturer’s instructions starting with 3 mg genomic rat DNA of MWF, SHR,
MWF-6SHR, MWF.SHR-(D6Rat1-D6Mgh4), and MWF.SHR-(D6Rat1-D6Rat81) (n = 3, each), uniquely
labelled by index tags.
Library quality control and final quantification for subsequent pooling of the 16 sequencing librar-
ies was performed using the 2100 Bioanalyzer instrument (Agilent Technologies). The pooled library
was paired end sequenced (2  76 cycles plus index read) on a MiSeq system (Illumina) using the
MiSeq reagent kit v3 (Illumina). The CASAVA software package v1.8.2 (Illumina) was used for demul-
tiplexing of the sequencing reads and conversion to fastq data for further analysis. The resulting
high-quality reads for identification of SNPs and short INDELs were mapped to the reference
genome according to the annotation release Rat Genome Sequencing Consortium (RGSC) genome
assembly v6.0 using BWA software, version 0.6.2 (Li and Durbin, 2009). Mapped reads were proc-
essed and calling of SNPs and short INDELs were performed by the GATK pipeline, version 2.8
(Van der Auwera et al., 2013). Effects of the genomic variations were evaluated with the SnpEff
software tool, version 3.3 (Cingolani et al., 2012). Impairment of protein function by common exonic
variants in MWF and SHR were analysed using the PROVEAN algorithm (Choi et al., 2012). A PRO-
VEAN Score <2.5 was considered significant for genes.
The Tajima’s D statistic (Tajima, 1989) was used to test for signatures of selection in the region of
interest utilizing the vcftools software (Vs. 0.1.13) (Danecek et al., 2011).
Rat glomeruli isolation
Different protocols were used for isolation of glomeruli from male rats at 4 and 8 weeks of age, due
to the different body size. Rats were anesthetized with ketamine-xylazine (87 and 13 mg/kg body
weight, respectively). In 4-week-old rats, the abdominal artery was catheterized and kidneys were
perfused with 10 ml 1x phosphate buffered saline (PBS) and subsequently with 20 ml ferrous solution
(12.5 g ferric oxide (Iron(II/III) powder <5 micron, 98%; Sigma- Aldrich Chemie GmbH) suspended in
1000 ml 1x PBS. Kidneys were removed, decapsulated and passed through a 125 mm steel sieve
(Retsch GmbH) with 1x PBS. The glomeruli containing ferrous particles were gathered by a magnet,
snap-frozen and stored at  80˚C. Kidneys of 8-week-old rats were removed, decapsulated and
passed through a 125 mm steel sieve with 1x PBS. The filtrate was put on a 71 mm steel sieve (Retsch
GmbH) to separate glomeruli from the flow-through. Glomeruli were washed off the sieve with 1x
PBS, centrifuged, immediately snap-frozen and stored at  80˚C.
Transcriptome analysis
RNA sequencing (RNA-Seq) was performed in glomerular RNA of male MWF and SHR rats at week
4 (n = 3, each). The NEBNext Poly(A) mRNA magnetic isolation module followed by library prepara-
tion using NEBNext Ultra RNA Library Prep Kit for Illumina (New England BioLabs) was applied on 1
mg total RNA to generate a cDNA library for subsequent paired end (80 cycles) sequencing on the
NextSeq 500 system (Illumina) using v2 chemistry yielding in about 415M single reads. RNA and
library quality control was performed using the Bioanalyzer RNA 600 Nano and High-Sensitivity DNA
Analysis Kit (Agilent Technologies), respectively. The KAPA Library Quantification Kit (Kapa Biosys-
tems) was used for library quantification.
Initial quality control of the raw data was performed using Cutadapt version 1.9 (Martin, 2012)
program. Raw reads were quality trimmed (minimal base quality: 25, minimal read length after trim-
ming: 70 nt), adapter sequences were removed from reads 3’ ends. TopHat2 version 2.1.0
(Trapnell et al., 2009; Trapnell et al., 2010) software tool together with Bowtie2 aligner version
2.2.3 (Langmead and Salzberg, 2012) was used for read mapping against ENSEMBL rn6.0 reference
assembly (Yates et al., 2016). After the reads have been mapped to the reference genome, the Cuf-
flinks version 2.2.1 (Trapnell et al., 2010) program together with Ensembl (release 81) gene annota-
tion (Aken et al., 2016), baw093) were used to assemble transcripts and estimate their abundances.
Differential expression analysis was performed using both Cuffdiff version 2.2.1 software package
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(Trapnell et al., 2010) and DESeq2 R package version 1.12.4 (Love et al., 2014). Genes having
absolute fold change value <1.5 were excluded from further analysis. Genes were considered signifi-
cantly differentially expressed if the corresponding adjusted p-value was less than 0.05.
Reverse transcription and qPCR
First-strand cDNA synthesis was carried out on 2 mg of total RNA using the First Strand cDNA Syn-
thesis Kit (Fermentas Life Sciences) following the manufacturer’s protocol. Isolated glomeruli prepa-
rations of rat strains were analyzed at week 4 and week 8. qPCR of each gene was performed in a
7000 Real-Time PCR System (Applied Biosystems) with version 1.2.3 software or a 7500 Fast Real-
Time PCR System with version 2.0.6 software (Applied Biosystems) using the comparative quantifica-
tion cycle method as reported (Fast SYBRGreen Master Mix or Power SYBR Green PCR Master Mix;
Applied Biosystems) (Schulz et al., 2008). Primers are listed in Figure 4—source data 2. Normaliza-
tion of expression data was done by the reference gene hydroxymethylbilane synthase (Hmbs)
(Schulz et al., 2008). For all analyses, three technical replicates of each animal/experiment were per-
formed. Genes with low mRNA expression levels were only considered when the quantification
cycles (Cqs) were 30 and the Cqs of the no-template controls were at least 5 Cqs delayed. Acyl-
CoA thioesterase 3 (Acot3) demonstrated low expression levels and was therefore not analyzed.
Immunohistochemistry of TMEM63C in rat and human kidneys
For determination of protein expression of TMEM63C an anti-TMEM63C antibody (epitope: G
LRGFARELDPAQFQEGLE, custom antibody production: Perbio Science Germany) was generated.
The epitope does not cross react with TMEM63A or TMEM63B or other genes. For Wilms tumor 1
(WT1) protein expression analysis, we used a rabbit anti-WT1 antibody (Santa Cruz). For nephrin pro-
tein expression analysis, we used a rabbit anti-nephrin antibody (Abcam). Paraffin embedded rat kid-
ney sections and human biopsy samples were cut at 4 mm and incubated with the anti-TMEM63C
antibody (1:1600 for rat tissue, 1:800 for human biopsies), the anti-WT1 antibody (1:500) or the anti-
nephrin antibody (1:750). Rabbit IgG negative control fraction was used as a negative control in the
same concentration as the primary antibody. Goat anti-rabbit EnVision HRP conjugate (Dako) was
used as secondary antibody. The staining was visualized using diaminobenzidine as the chromogen
and counterstained with haematoxylin.
Evaluation of TMEM63C staining in MWF and SHR rats
Consecutive slides of MWF and SHR kidney sections stained for TMEM63C and WT1 were evaluated
to determine TMEM63C co-localization with podocytes. TMEM63C protein level in glomeruli was
analyzed using ImageJ analysis.
Table 4. Characteristics of focal segmental glomerulosclerosis patients.
Patient-specific features Values‡
Number of patients 9
Age, years 36 ± 23
Sex, male 5 (55%)
SBP, mmHg* 167 ± 38
DBP, mmHg† 106 ± 25
Hypertension 7 (88%)
Proteinuria, g/day† 9.2 ± 4.4
Serum creatinine, mmol/l† 150 ± 43
eGFR, ml/min/1.73 m2* 51 (42–66)
Nephrotic syndrome 8 (89%)
*n = 7; †n = 6; ‡ values are reported as number (%), mean ±SD or as median (interquartile range) for eGFR.
DOI: https://doi.org/10.7554/eLife.42068.032
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FSGS patients
Renal biopsy samples of patients with FSGS (Table 4) were collected from the archive of the Depart-
ment of Pathology of the Leiden University Medical Center (LUMC). Demographic data and labora-
tory data at time of biopsy were retrospectively retrieved from the patients’ medical records or
pathology reports following the good practice guidelines of the LUMC. All biopsy samples were han-
dled and analyzed anonymously in accordance with the Dutch National Ethics Guidelines (Code for
Proper Secondary Use of Human Tissue, Dutch Federation of Medical Scientific Societies). This study
is in agreement with the Declaration of Helsinki and the Department of Health and Human Services
Belmont Report and the use of the patient biopsies was approved by the medical ethical committee
of the LUMC (registration number G16.110). Samples obtained from Eurotransplant donors that
were unsuited for transplantation because of technical problems, were used as healthy controls. All
sections were scored separately by two observers for TMEM63C intensity as well as for percentage
of glomeruli with loss of TMEM63C staining. Each case was given a score for TMEM63C staining
intensity: high intensity in >50% of glomeruli, intermediate intensity in >50% of glomeruli, low inten-
sity in >50% of glomeruli or no TMEM63C staining present in >50% of glomeruli. Secondly, sections
were scored based on the percentage of glomeruli with loss of TMEM63C expression in podocytes.
Per case, the percentage of glomeruli with 1) no loss 2) <25% loss 3) 25–50% loss or 4) >50% loss of
TMEM63C expression in podocytes was determined. For nephrin staining analysis, each glomerulus
was scored based on staining pattern (linear or granular) and loss of staining (no loss, segmental loss
or global loss).
All biopsy samples were handled and analyzed anonymously in accordance with the Dutch
National Ethics Guidelines (Code for Proper Secondary Use of Human Tissue, Dutch Federation of
Medical Scientific Societies) and in agreement with the Declaration of Helsinki and the Department
of Health and Human Services Belmont Report. The use of the patient biopsies was approved by the
medical ethical committee of the LUMC.
Cell lines
Immortalized human podocytes (RRID:CVCL_W186, a kind gift from Professor Moin Saleem, MA,
Academic and Children’s Renal Unit, University of Bristol, Bristol, UK) (Saleem et al., 2002) were
used as described (Eisenreich et al., 2016). The cell line has previously been authenticated
(Saleem et al., 2002) and we have confirmed this by expression of podocyte specific markers such
as podocin and synaptopodin as recently reported (Eisenreich et al., 2016). The cell line tested neg-
ative for mycoplasma contamination. Before transfection, human podocytes were starved with FBS-
free RPMI 1640 medium overnight. Transfection of cells was performed using 200 nM of TMEM63C-
specific siRNAs (siTMEM63C; Sigma-Aldrich Chemie GmbH) or non-sense control siRNAs (siControl;
Sigma-Aldrich Chemie GmbH) as well as Lipofectamine 2000 (Life Technologies GmbH). The trans-
fection efficacy of 25% in human podocytes was experimentally determined earlier
(Eisenreich et al., 2016).
Western blotting
Western blot analyses were done as described earlier (Eisenreich et al., 2016; Langer et al.,
2016). For detection, specific antibodies against TMEM63C (Thermo Fisher Scientific), GAPDH (Cal-
biochem), protein kinase B (AKT; Merck Chemicals GmbH), and phospho-AKT (Ser473, pAKT; Merck
Chemicals GmbH) were used. Quantification of Western blot analyses were done using Gel-Pro Ana-
lyzer software version 4.0.00.001 (Media Cybernetics).
Cytochrome C releasing apoptosis assay
The cytochrome C releasing apoptosis assay kit (BioVision Inc) was used following the manufacturer’s
protocol as described previously (Eisenreich et al., 2016). In brief, 1  104 cells per well were trans-
fected for 48 hr with siTMEM63C or siControl, respectively. After that, cells were lysed and the cyto-
solic fraction was separated from the mitochondrial fraction. Comparative Western blot analyses of
these fractions using a cytochrome C-specific antibody were performed to determine pro-apoptotic
translocation of cytochrome C from mitochondria into cytosol.
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Cell viability assay
The calcein AM (acetoxymethyl) cell viability kit (Trevigen Inc) was used as earlier described following
the manufacturer’s protocol (Eisenreich et al., 2016). In brief, 1  104 cells per well were transfected
for 48 hr with siTMEM63C or siControl, respectively. Then, human podocytes were washed and incu-
bated with calcein AM working solution for 30 min. Fluorescence was measured at 490 nm excitation
and 520 nm emission.
Zebrafish animals
Zebrafish were bred, raised and maintained in accordance with the guidelines of the Max Delbru¨ck
Center for Molecular Medicine and the local authority for animal protection (Landesamt fu¨r Gesund-
heit und Soziales, Berlin, Germany) for the use of laboratory animals, and followed the ‘Principles of
Laboratory Animal Care’ (NIH publication no. 86–23, revised 1985) as well as the current version of
German Law on the Protection of Animals.
Zebrafish morpholino and single guide RNA (sgRNA) microinjections
Injection droplets of approximately 1 nl were injected into one-cell stage zygotes of the zebrafish
wild type hybrid strain AB/Tu¨lf and the transgenic lines Tg(fabp10a:gc-EGFP) (Zhou and Hilde-
brandt, 2012) and Tg(wt1b:GFP) (Bollig et al., 2009; Perner et al., 2007). Morpholinos (MO) of the
following sequences were synthesized by Gene Tools LLC Philomath: tmem63c ATG-MO 5’-CAGGC-
CAGGACTCAAACGCCATTGC-3’, tmem63c ex2-sdMO 5’-TGTTATCATAGATGATGTACCAGCC-3’,
and standard control oligo (Control-MO) 5’-CCTCTTACCTCAGTTACAATTTATA-3’. Tmem63c ATG-
MO was used at a final concentration of 0.3 mM (Figure 7B), tmem63c ex2-sdMO was used at a final
concentration of 0.5 mM (Figure 7—figure supplement 1). sgRNA targeting exon 2 (Figure 7B) was
generated as described (Bassett et al., 2013; Burger et al., 2016) using the ex2-sgRNA forward
primer with CRISPR target site underlined: GAAATTAATACGACTCACTATAGGACGTCAGGAG
TTTCCTGAGTTTTAGAGCTAGAAATAGC and the invariant reverse primer: AAAAGCACCGAC
TCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTC
TAAAAC. PCR product was purified with GeneJET Gel Extraction Kit (Thermo Fisher Scientific,
respectively). sgRNA was transcribed using the MEGAscript T7 Kit (Ambion) and extracted with
RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. sgRNA was diluted to a final
concentration of 159.6 ng/ml or 250 ng/ml, respectively using water and 1 M KCl (final concentration:
300 mM) and co-injected with Cas9-Protein of 600 ng/ml final concentration as described
(Burger et al., 2016; Gagnon et al., 2014). To determine the efficiency of sgRNA-mediated muta-
genesis crispants alleles were analyzed as described (Figure 7—figure supplement 1D)
(Burger et al., 2016). The following primers (BioTez Berlin-Buch GmbH) were used to amplify the
genomic region flanking the CRISPR target site; forward: CAAATGGTGAACACTTGTGAATC,
reverse: CTGCGGTTTACTGCGGAGATG. Computational sequence analysis was performed using
CrispR Variants (Lindsay et al., 2016). For an injection control Cas9 was diluted to a final concentra-
tion of 600 ng/ml using water and 1 M KCl (final concentration: 300 mM; Cas9-Control).
Reverse transcriptase (RT)-PCR in zebrafish embryos
For efficiency analysis of the tmem63c ex2-sdMO a reverse transcriptase (RT)-PCR was carried out
(Figure 7—figure supplement 1F). At 24 hpf, RNA from 50 pooled embryos was isolated using Tri-
zol Reagent (Invitrogen); DNase I digestion was performed using the RNAse-free DNase set (Qiagen)
and samples were purified using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s pro-
tocol. After determination of RNA quality and quantity, equal amounts of mRNA for each group ana-
lyzed were transcribed to cDNA using First strand cDNA synthesis kit (Thermo Fisher) according to
the manufacturer’s protocol.
We amplified tmem63c from cDNA using DreamTaq DNA Polymerase (Thermo Fisher) with the
following primers: forward: CTGATGGAGGAGAACAGCACGG, reverse: ATACAGCAGAGCGAAGA
TACTGTG. Eucaryotic elongation factor 1 alpha 1, like 1 (eef1a1l1) was used as a loading control
and amplified using the following primers: forward: TGGAGACAGCAAGAACGACC, reverse: GAGG
TTGGGAAGAACACGCC.
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Cloning of tmem63c cDNA (Danio rerio)
Primers (BioTez Berlin-Buch GmbH) for the In-Fusion HD Cloning Kit (Takara) were designed using
the web tool provided by TaKaRa (TaKaRa) (TaKaRa, 2018); forward: GCTTGATATCGAATTCA
TGGCGTTTGAGTCCTGGCCTGC, reverse: CGGGCTGCAGGAATTCTCACTGAAAAGCCACCGGAC
TG. tmem63c cDNA was amplified using Phusion High-Fidelity DNA polymerase (Thermo Fisher Sci-
entific). The pBluescript II SK(+) vector was linearized using EcoRI FD enzyme. The tmem63c ORF
was cloned into the pBluescript II SK (+) vector using the In-Fusion HD Cloning Kit (Takara). The
tmem63c cDNA was sequence-verified using the common T7 forward and M13 reverse primers. For
sequencing of the whole ORF, an additional primer was used, GTGCAGAAACTAATGAAGCTGG,
located at 822–844 bp starting from the beginning of the ORF.
Rescue of CRISPR/Cas9-mediated tmem63c somatic mutants and
tmem63c ex2-sdMO-mediated gene knockdown
For in vivo rescue experiments tmem63c cDNA (Danio rerio) was linearized using ApaI FD (Thermo
Fisher Scientific) and purified using GeneJET Gel Extraction Kit (Thermo Fisher Scientific). In vitro
transcription of capped RNA and following TurboDNase treatment were performed using mMessage
mMachine T7 Kit (Ambion). For poly-A-tailing, the Poly(A)-tailing Kit (Ambion) was used, followed by
RNA extraction using RNeasy Mini Kit (Qiagen). The mRNA was diluted to a concentration of 100
ng/ml and injected into one-cell stage zygotes. For in vivo rescue experiments, mRNA of a concentra-
tion of 100 ng/ml and ex2-sgRNA of a concentration of 159.6 ng/ml were subsequently injected into
the same one-cell stage zygotes. For in vivo rescue of the tmem63c ex2-sdMO-mediated knock-
down, mRNA with a concentration of 100 ng/ml and ex2-sdMO with a concentration of 0.5 mM were
subsequently injected into the same zygote at one- or one-to-four cell stage, respectively.
Rescue of tmem63c ATG-MO-mediated gene knockdown
Tmem63c cDNA (Rattus norvegicus) was synthesized by Thermo Fisher Scientific using their GeneArt
Gene synthesis service. For in vivo rescue experiments, Tmem63c cDNA was linearized using XbaI
FD (Thermo Fisher Scientific) and purified using GeneJET Gel Extraction Kit (Thermo Fisher Scien-
tific). In vitro transcription of capped RNA followed by TurboDNase treatment were performed using
mMessage mMachine T7 Kit (Ambion). For poly-A-tailing, the Poly(A)-tailing Kit (Ambion) was used,
followed by RNA extraction by RNeasy Mini Kit (Qiagen). The mRNA was diluted to a concentration
of 100 ng/ml and injected into one-cell stage zygotes. For in vivo rescue of the tmem63c ATG-MO-
mediated knockdown, mRNA with a concentration of 100 ng/ml and ATG-MO with a concentration
of 0.3 mM were subsequently injected into the same zygote at one- or one to four cell-stage,
respectively.
Functional assessment of the GFB
To assess the functionality of the GFB, the gc-EGFP fluorescence in the trunk vasculature of Tg
(fabp10a:gc-EGFP) embryos were evaluated at 120 hpf by epifluorescence microscopy. For CRISPR-
Cas9-mediated somatogenesis of tmem63c the above described sgRNA was used in a concentration
of 159.6 ng/ml. Each embryo was visually assigned to the ‘fluorescent group’, ‘deficient-fluorescent
group’, or ‘crippled/dead’ and their number quantified. Due to the heterogeneous genotype of the
used transgenic Tg(fabp10a:gc-EGFP) zebrafish families, the ‘deficient-fluorescent group’ included
the embryos with reduced fluorescence in the trunk as well as embryos that did not carry the trans-
gene (Figure 7—figure supplement 1A–C). The percentage of injected embryos was normalized to
the percentage of the control group for each category. Quantifications were performed for at least
three individual injections.
Electron microscopy in zebrafish embryos
Tg(fabp10a:gc-EGFP) embryos at 120 hpf were fixed in 4% formaldehyde/0.5% glutaraldehyde (EM-
grade) in 0.1 M phosphate buffer for 2 hr at RT. For knockdown analysis embryos were injected with
tmem63c ex2-sgRNA of a concentration of 250 ng/ml to enhance the observed phenotype
(Figure 7E,F). Prior to analysis embryos were sorted for a clear knockdown phenotype. Samples
were stained with 1% OsO4 for 2 hr, dehydrated in a graded ethanol series and propylene oxide and
embedded in Poly/BedR 812 (Polysciences, Eppelheim, Germany). Ultrathin sections were contrasted
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with uranyl acetate and lead citrate. Sections were examined with a FEI Morgagni electron micro-
scope and a Morada CCD camera (EMSIS GmbH, Mu¨nster, Germany). Image acquisition and quanti-
fication of podocyte foot process width and number of slit diaphragms per mm GBM was performed
with the iTEM software (EMSIS GmbH, Mu¨nster, Germany).
Confocal microscopy of zebrafish embryos and quantification of
podocyte cell number and glomerular volume
Tg(wt1b:EGFP) embryos at 96 hpf were fixed in PEM buffer containing 4% formaldehyde and 0.1%
Triton-X 100 for 2 hr at RT or overnight at 4˚C. For knockdown analysis embryos were injected with
tmem63c ex2-sgRNA with a concentration of 250 ng/ml to enhance the observed phenotype. Nuclei
were stained using 40,6-Diamidin-2-phenylindol (DAPI, Sigma Aldrich, stock solution 1 mg/ml diluted
1:2000 in PBS) overnight at 4˚C. After removal of the yolk and mounting in 0,7% low-melting aga-
rose, the kidneys of whole-mount fixed embryos were imaged using a Zeiss LSM 710 or LSM 700
microscope with a LD C-Apochromat 40 x NA1.1 water objective and ZEN 2.1 software by sequen-
tially acquiring confocal z-stacks of the GFP (488 nm laser, emission 495–550 nm) and the DAPI sig-
nal (405 nm laser, emission 420–480 nm) with a pixel size of 102.4 nm. Care was taken to apply
identical settings to all samples and not to oversaturate pixels.
Quantification of podocyte cell number and glomerular volume was done using Imaris version
9.21 software (RRID:SCR_007370, Bitplane AG, Zurich, Switzerland). A 3D surface covering the total
glomerular volume was manually edited by tracing the outlines of EGFP-positive cells for every sec-
ond section of the z-stack. EGFP-positive cells of the glomerulus were included, while cells of the
pronephric ducts were excluded. For quantification of podocyte cell number, the DAPI channel was
masked with the EGFP channel using Fiji software (RRID:SCR_002285) (Schindelin et al., 2012) to
include DAPI+/EGFP+ cells only, thus representing nuclei of podocyte cells. Subsequently, a spot
segmentation of the DAPI channel was performed. Estimated spot diameter was 4 mm. Spots were
filtered for a minimum intensity of the EGFP channel and by using the Imaris quality filter for the
occurrence of unspecific spots not matching the EGFP signal. Spots located outside the glomerular
surface were manually deleted.
Statistics
Data are presented as mean ±SD for normally distributed data or median (25% percentile – 75% per-
centile, that is interquartile range [IQR]) for non-normally distributed data with the indicated number
of experiments. Normal distribution was determined using the Shapiro-Wilk test. For identification
of outliers, Grubbs’ outliers test (a = 0.05) was performed. Where appropriate, sample size calcula-
tions were performed by the power analyses program G*Power according to Cohen (Cohen, 1988;
Faul et al., 2009). Differences between experimental rat and zebrafish groups were analyzed using
One-way ANOVA with post-hoc Bonferroni’s multiple comparisons test and non-parametric Mann-
Whitney-U or Kruskall-Wallis test with Dunn’s multiple comparisons post-hoc test, when appropriate.
For the analysis shown in Figure 7L and Figure 7—figure supplement 1I Gaussian distribution was
assumed due to the number of embryos categorized. Differences between FSGS patients and con-
trols were analyzed using the Linear-by-Linear association test and the Mann-Whitney U test. Differ-
ences in human cultured podocytes were analyzed using two-tailed Student’s t-test. Statistical
analysis was performed using SPSS and GraphPad Prism 6 software 6.00 (RRID:SCR_002798, Graph-
Pad Software, La Jolla, CA). p values < 0.05 were considered as statistically significant.
Data availability
The genomic and transcriptomic data from this publication have been deposited to the NCBI
(https://www.ncbi.nlm.nih.gov/) curated repositories, GEO, and SRA, and assigned the identifier
SubmissionID: SUB2950675 and BioProject ID: PRJNA398197 (DNA-Seq) and accession GSE102546
(RNA-Seq).
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